Nanopowder Production and Characteristics - PowerPoint PPT Presentation

1 / 60
About This Presentation
Title:

Nanopowder Production and Characteristics

Description:

* i. Drug loading MS mass spectrometry (GCMS, TOFMS, SIMS, etc.) HPLC High performance liquid chromatography UV-Vis ... The supercritical fluid ... – PowerPoint PPT presentation

Number of Views:237
Avg rating:3.0/5.0
Slides: 61
Provided by: Sta7110
Category:

less

Transcript and Presenter's Notes

Title: Nanopowder Production and Characteristics


1
Nanopowder Production and Characteristics
  • Prof. Dr. Basavaraj K. Nanjwade M. Pharm., Ph. D
  • Department of Pharmaceutics
  • KLE University College of Pharmacy
  • BELGAUM-590010
  • Cell No 0091-9742431000
  • E-mail nanjwadebk_at_gmail.com

2
Nanotechnology
3
Nanotechnology
  • Nanotechnology may be defined as the ability to
    work at the molecular level, atom by atom, to
    create large structure with fundamentally new
    molecular organization.
  • Many pharmaceutical companies are performing
    research to decline the particle size.
  • If drugs were able to have smaller particle size
    they would be better absorbed by digestive tract
    lining therefore the amount necessary would be
    reduced making medicines more affordable.

4
Manufacturing Methods
  • Several mechanically or chemically based methods
    are currently in use to manufacture
    nanomaterials.
  • Major mechanical methods include ball milling,
    laser ablation, etching, sputtering, sonification
    and electroexplosion.
  • Major chemical methods include chemical vapor
    deposition (CVD), sol-gel processing and
    molecular pyrolysis.

5
What is a Nanopowder
  • Nanopowder is a material fabricated on the
    nanoscale with grain and feature sizes typically
    under 100 nanometres.
  • The basis of nanotechnology is the ability to
    form nano-sized particles, for example
    nanopowders, which are solid particles that
    measure on the nanoscale.
  • Nanopowders have been of extreme interest in the
    pharmaceutical field.
  • Drug delivery has been impacted in several ways
    due to the advances in nanopowder technology.

6
Production of Nanopowder
  • Conventional Methods
  • - Milling, grinding, jet milling, crushing,
    and air micronization
  • Super Critical Fluids (SCF)
  • Rapid Expansion of Supercritical Solutions (RESS)
  • Supercritical Anti-Solvent (SAS)
  • Aerosol Solvent Extraction System (ASES)
  • Solution Enhanced Dispersion by Supercritical
    fluids (SEDS)
  • Particles from Gas Saturated Solutions (PGSS)
  • Depressurization of Expanded Liquid Organic
    Solution (DELOS)

7
Conventional Methods
  • Conventional methods of particle size reduction
    include milling, grinding, jet milling, crushing,
    and air micronization.
  • CM might not accomplish the desired amount of
    particle size reduction.
  • CM drawback is associated with the physical and
    chemical properties of the materials undergoing
    size reduction.
  • Certain compounds are chemically sensitive or
    thermo-liable, such as explosives, chemical
    intermediates, or pharmaceuticals which can not
    be processed using conventional methods due to
    the physical effects of these methods.

8
Super Critical Fluid
  • A SCF is defined as a substance above its
    critical temperature (T) and critical pressure
    (P).
  • The critical point represents the highest
    temperature and pressure at which the substance
    can exist as a vapor and liquid in equilibrium.

9
Rapid Expansion of Supercritical Solutions
(RESS)
  • Rapid Expansion of Supercritical Solutions (RESS)
    is a crystallization technique that uses the
    properties of a supercritical fluid, typically
    CO2, as a solvent to facilitate nanopowder
    production.
  • The RESS process is described in two steps
    solubilization and particle formation.
  • The driving force for this process is caused by
    the rapid depressurization of the supercritical
    fluid dissolved with the solute of interest
    through a nozzle to cause fast nucleation and
    fine particle generation

10
Schematic of RESS Process
11
Supercritical Anti-Solvent
  • The Supercritical Anti-Solvent process (SAS) uses
    solvent/anti-solvent binary systems to induce the
    formation of nano and micro-size particles.
  • The supercritical fluid (i.e. CO2) acts as an
    anti-solvent that causes the crystallization of
    the solute.
  • The main driving force for this process is the
    droplet formation, which is caused by the
    solvent/anti-solvent interaction.

12
Schematic of SAS Process
13
Aerosol Solvent Extraction System (ASES)
  • ASES method involves spraying the solution as
    fine droplets into the supercritical fluid.
  • The dissolution of the supercritical fluid is
    followed by a large volume expansion, which is
    called the anti-solvent effect.
  • This cause a reduction in the liquid solvating
    power and a sharp increase in the supersaturated
    within the liquid mixture, which leads to small
    and uniform particles

14
Schematic of ASES Process
15
Solution Enhanced Dispersion System(SEDS)
  • SEDS method was developed to achieve smaller
    droplet size and intense mixing of supercritical
    fluid and solution for increased mass transfer
    rates.
  • The supercritical fluid is used for its chemical
    properties and as a spray enhancer by
    mechanical effects.

16
Schematic of SEDS Process
17
Particle From gas Saturated Solution (PGSS)
  • The Particle from Gas Saturated Solution (PGSS)
    process uses a SCF, usually CO2, as a solute to
    crystallize a solution.
  • The PGSS process can be used to create micro and
    nano sized particles with the ability to control
    particle size distribution.
  • The driving force of the PGSS is a sudden
    temperature drop of the solution below the
    melting point of the solvent.

18
Particle From gas Saturated Solution (PGSS)
  • This occurs as the solution is expanded from a
    working pressure to atmospheric conditions due to
    the Joule-Thompson effect.
  • The rapid cooling produces amorphous powder which
    is mainly used in pharmaceutical industries.

19
Schematic of PGSS Process
20
Depressurization of an Expanded Liquid
Organic Solution (DELOS)
  • Depressurization of an expanded liquid organic
    solution (DELOS) is a process that uses a
    supercritical fluid, as a co-solvent for the
    formation of micro and nano- sized particles.
  • DELOS process is best for organic solutes in
    organic solvents and it is particularly useful
    for pharmaceuticals, dyes, and polymers, where
    conventional methods of particle size reduction
    tend to be ineffective due to physical and
    chemical limitations

21
Schematic of DELOS Process
22
Applications of Nanopowders
  • Nanopowder has many applications in different
    fields
  •  
  • Ceramics used in nano sized powders are more
    ductile at elevated temperatures compared to
    coarse grained ceramics and can be sintered at
    low temperatures
  • Nano sized powders of iron and copper have
    hardness about 4-6 times higher than the bulk
    materials because bulk materials have
    dislocations.
  • Nano sized copper and silver are used in
    conducting ink and polymers
  •  

23
Applications of Nanopowders
  • Nano powder has various applications in the
    pharmaceutical and medical field.
  • Drug delivery has impacted by the advancement in
    nano powders smaller particles are able to be
    delivered in new ways to patients, through
    solutions, oral or injected, and aerosol, inhaler
    or respirator.
  • New production processes allow for encapsulation
    of pharmaceuticals which allow for drug delivery
    where needed with in the body.

24
Nanopowder Characteristics
  • 1. Morphology
  • 2. Surface
  • 3. Chemical
  • 4. Other

25
1. MORPHOLOGY
  • i. Size (Primary particle)
  • ii. Size (Primary/aggregate/agglomerate)
  • iii. Size distribution
  • iv. Molecular weight
  • v. Structure/Shape
  • vi. Structure/Shape(3D structure)

26
i. Size (Primary particle)
  • a. TEM Transmission electron microscopy
  • b. SEM Scanning electron microscopy
  • c. AFM Atomic absorption spectroscopy
  • d. XRD X-ray diffraction

27
ii. Size (primary/aggregate/agglomerate)
  • a. TEM Transmission electron microscopy
  • b. SEM Scanning electron microscopy
  • c. AFM Atomic force microscopy
  • d. DLS Dynamic light scattering
  • e. FFF Field flow fractionation
  • f. AUC Analytical ultracentrifugation
  • g. CHDF Capillary hydrodynamic fractionation
  • h. XDC X-ray disk centrifuge
  • i. HPLC High performance liquid chromatography
  • j. DMA(1) Differential mobility analyzer

28
iii. Size distribution
  • a. TEM Transmission electron microscopy
  • b. SEM Scanning electron microscopy
  • c. AFM Atomic force microscopy
  • d. DLS Dynamic light scattering
  • e. AUC Analytical ultracentrifugation
  • f. FFF Field flow fractionation
  • g. HPLC High performance liquid chromatography
  • h. SMA Scanning mobility particle sizer

29
iv. Molecular weight
  • a. SLS Static light scattering
  • b. AUC Analytical ultracentrifugation
  • c. GPC Gel permeation chromatography

30
v. Structure Shape
  • a. TEM Transmission electron microscopy
  • b. SEM Scanning electron microscopy
  • c. AFM Atomic force microscopy
  • d. NMR Nuclear magnetic resonance

31
vi. Stability (3D structure)
  • a. DLS Dynamic light scattering
  • b. AUC Analytical ultracentrifugation
  • c. FFF Field flow fractionation
  • d. SEM Scanning electron microscopy
  • e. TEM Transmission electron microscopy

32
2. SURFACE
  1. Surface area
  2. Surface charge
  3. Zeta potential
  4. Surface coating composition
  5. Surface coating coverage
  6. Surface reactivity
  7. Surface-core interaction
  8. Topology

33
i. Surface area
  • a. BET Brunauer, Emmett, and Teller method

34
ii. Surface charge
  • a. SPM Surface probe microscopy (AFM, STM,
    NSOM/SNOM, etc)
  • b. GE Gel electrophoresis
  • c. Titration methods -

35
iii. Zeta potential
  • a. LDE Laser doppler electrophoresis
  • b. ESA Electroacoustic spectroscopy
  • c. PALS Phase analysis light scattering

36
iv. Surface coating composition
  • a. SPM Surface probe microscopy (AFM, STM,
    NSOM/SNOM, etc.)
  • b. XPS X-ray disk centrifuge
  • c. MS Mass spectrometry (GCMS, TOFMS, SIMS,
    etc.)
  • d. RS Raman spectroscopy
  • e. FTIR Fourier transform infrared spectroscopy
  • f. NMR Nuclear magnetic resonance

37
v. Surface coating coverage
  • a. AFM Atomic force microscopy
  • b. AUC Analytical ultracentrifugation
  • c. TGA Thermal gravimetric analysis

38
vi. Surface reactivity
  • a. Varies with nanomaterial

39
vii. Surface-core interaction
  • a. SPM Surface probe microscopy (AFM, STM,
    NSOM, etc. )
  • b. RS Raman spectroscopy
  • c. ITC Isothermal titration calorimetry
  • d. AUC Analytical ultracentrifugation
  • e. GE Gel electrophoresis

40
viii. Topology
  • a. SEM Scanning electron microscopy
  • b. SPM Surface probe microscopy (AFM, STM,
    NSOM/SNOM, etc.)
  • c. MS Mass spectrometry (GCMS, TOFMS, SIMS,
    etc.)

41
3. CHEMICAL
  1. Chemical composition (core, surface)
  2. Purity
  3. Stability (chemical)
  4. Solubility (chemical)
  5. Structure (chemical)
  6. Crystallinity
  7. Catalytical activity

42
i. Chemical composition (core, surface)
  • a. XPS X-ray photoelectron spectroscopy
  • b. MS Mass spectrometry (GCMS, TOFMS, SIMS,
    etc.)
  • c. AAS Atomic absorption spectroscopy
  • d. ICP-MS Inductively coupled plasma mass
    spectrometry
  • e. RS Raman spectroscopy
  • f. FTIR Fourier transform infrared spectroscopy
  • g. NMR Nuclear magnetic resonance

43
ii. Purity
  1. ICP-MS - Inductively coupled plasma mass
    spectrometry
  2. AAS Atomic absorption spectroscopy
  3. AUC Analytical ultracentrifugation
  4. HPLC High performance liquid chromatography
  5. DSC Differential scanning calorimetry

44
iii. Stability (chemical)
  1. MS Mass spectrometry (GCMS, TOFMS, SIMS, etc.)
  2. HPLC High performance liquid chromatography
  3. RS Raman spectroscopy
  4. FTIR Fourier transform infrared spectoscopy

45
iv. Solubility (chemical)
  • a. Varies with nanomaterial

46
v. Structure (chemical)
  1. NMR Nuclear magnetic resonance
  2. XRD X-ray diffraction

47
vi. Crystallinity
  1. XRD - X-ray diffraction
  2. DSC Differential scanning calorimetry

48
viii. Catalytic activity
  • Varies with nanomaterial

49
4. OTHER
  1. Drug loading
  2. Drug potency/functionality
  3. In vitro release (detection)
  4. Deformability

50
i. Drug loading
  1. MS mass spectrometry (GCMS, TOFMS, SIMS, etc.)
  2. HPLC High performance liquid chromatography
  3. UV-Vis Ultraviolet-visible spectrometry
  4. Varies with nanomaterial

51
ii. Drug potency/functionality
  • a. Varies with nanomaterial

52
iii. In vitro release (detection)
  1. UV-Vis - Ultraviolet-visible spectrometry
  2. MS Mass spectrometry (GCMS, TOFMS, SIMS, etc.)
  3. HPLC High performance liquid chromatography
  4. Varies with nonmaterial

53
iv. Deformability
  1. AFM Atomic force microscopy
  2. DMA(2) Dynamic mechanical analyzer

54
Instruments for Nanocharacterstics
AAS
AFM
AUC
CHDF
DLS
BET
55
Instruments for Nanocharacterstics
DMA(1)
DMA(2)
DSC
ESA
FFF
56
Instruments for Nanocharacterstics
FTIR
GE
GPC
ITC
HPLC
ICP-MS
57
Instruments for Nanocharacterstics
LDE
MS
NMR
SEM
PALS
RS
58
Instruments for Nanocharacterstics
SLS
SMA
SPM
TEM
UV-Vis
XDC
XPS
XRD
TGA
59
Conclusion
RESS PGSS DELOS
Application Small Mol High purity Large Mol
Role of SCF Solvent Solute Co Solvent
Driving force Pressure Temperature Temperature
Working pressure Dependence SCF Morphology SCF
Working temperature dependence SCF Highest SCF
Length of procedure 2 Steps 2 Steps 3 Steps
Particle size Micro Nano Micro Nano Micro Nano
Encapsulation Yes Yes Yes
60
THANK YOUCell No 0091-9742431000E-mail
nanjwadebk_at_gmail.com
Write a Comment
User Comments (0)
About PowerShow.com